Bone marrow mononuclear stem cells: potential in the treatment of myocardial infarction
Anne-Laure Leblond, John O’Sullivan, Noel Caplice1Centre for Research in Vascular Biology (CRVB), Biosciences Institute, University College Cork, Cork, IrelandAbstract: Despite advances in the management of myocardial infarction, congestive heart failure following myocardial infarction...
Saved in:
Main Authors: | Anne-Laure Leblond, John O’Sullivan, Noel Caplice |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2009
|
Subjects: | |
Online Access: | https://doaj.org/article/f06cc6aac9c4480c986f918d30eff0fe |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
M1 Bone Marrow-Derived Macrophage-Derived Extracellular Vesicles Inhibit Angiogenesis and Myocardial Regeneration Following Myocardial Infarction via the MALAT1/MicroRNA-25-3p/CDC42 Axis
by: Bairong Chen, et al.
Published: (2021) -
Hematopoietic stem cells: ex-vivo expansion and therapeutic potential for myocardial ischemia
by: Jingwei Lu, et al.
Published: (2010) -
Human adipose stem cell and ASC-derived cardiac progenitor cellular therapy improves outcomes in a murine model of myocardial infarction
by: Davy PMC, et al.
Published: (2015) -
Autologous bone marrow cell therapy for peripheral arterial disease
by: Botti C, et al.
Published: (2012) -
Stem cell technology for bone regeneration: current status and potential applications
by: Asatrian G, et al.
Published: (2015)